Captopril and Oesophageal obstruction - a phase IV clinical study of FDA data


Oesophageal obstruction is reported only by a few people who take Captopril.

The phase IV clinical study analyzes which people take Captopril and have Oesophageal obstruction. It is created by eHealthMe based on reports of 16,585 people who have side effects while taking Captopril from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

16,585 people reported to have side effects when taking Captopril.
Among them, 3 people (0.02%) have Oesophageal obstruction.

What is Captopril?

Captopril has active ingredients of captopril. It is often used in high blood pressure. eHealthMe is studying from 16,732 Captopril users for its effectiveness, alternative drugs and more.

What is Oesophageal obstruction?

Oesophageal obstruction (blockage of oesophagus) is found to be associated with 487 drugs and 209 conditions by eHealthMe.

Number of Captopril and Oesophageal obstruction reports submitted per year:

Could Captopril cause Oesophageal obstruction?

Gender of people who have Oesophageal obstruction when taking Captopril *:

  • female: 33.33 %
  • male: 66.67 %

Age of people who have Oesophageal obstruction when taking Captopril *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Captopril *:

  1. Sutent: 1 person, 33.33%
  2. Spiriva: 1 person, 33.33%
  3. Mobic: 1 person, 33.33%
  4. Minipress: 1 person, 33.33%
  5. Lipitor: 1 person, 33.33%
  6. Lantus: 1 person, 33.33%
  7. Humalog: 1 person, 33.33%
  8. Fosamax: 1 person, 33.33%
  9. Coumadin: 1 person, 33.33%
  10. Aldomet: 1 person, 33.33%

Common side effects people have besides Oesophageal obstruction *:

  1. Weight Decreased: 1 person, 33.33%
  2. Swallowing Difficulty: 1 person, 33.33%
  3. Oesophageal Ulcer (ulcer of oesophagus): 1 person, 33.33%
  4. Oesophageal Stenosis (narrowing of oesophagus): 1 person, 33.33%
  5. Oesophageal Pain: 1 person, 33.33%
  6. Gastritis Atrophic (process of chronic inflammation of the stomach mucosa): 1 person, 33.33%
  7. Blood Glucose Increased: 1 person, 33.33%

Common conditions people have *:

  1. Gastrointestinal Carcinoma (cancer of stomach or intestine): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Captopril and have Oesophageal obstruction?

Check whether Oesophageal obstruction is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Oesophageal obstruction and when was it recovered:

Expand to all the drugs that have ingredients of captopril:

Alternative drugs to, pros and cons of Captopril:

Common Captopril side effects:

Browse all side effects of Captopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Oesophageal obstruction treatments and more:

COVID vaccines that are related to Oesophageal obstruction:

All the drugs that are associated with Oesophageal obstruction:

All the conditions that are associated with Oesophageal obstruction:

How the study uses the data?

The study uses data from the FDA. It is based on captopril (the active ingredients of Captopril) and Captopril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: